Anti-tumor necrosis factor-alpha agents and uses thereof
The present invention relates to polypeptides comprising one or more antibody single domains, or antigen-binding fragments thereof, directed against Tumor Necrosis Factor-alpha, in particular, two light chain variable domains in dimeric form, wherein the dimer has high solubility. It also relates to...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO FERREIRA LLORENTE GRANCHO LOURENCO SARA VOLKER CORTE-REAL SOFIA CASTANHEIRA AIRES DA SILVA FREDERICO NUNO |
| description | The present invention relates to polypeptides comprising one or more antibody single domains, or antigen-binding fragments thereof, directed against Tumor Necrosis Factor-alpha, in particular, two light chain variable domains in dimeric form, wherein the dimer has high solubility. It also relates to methods of using anti-Tumor Necrosis Factor-alpha polypeptides in treating inflammatory disorders, including rheumatoid arthritis. Compositions and methods for enhancing therapeutic potential of anti-Tumor Necrosis Factor-alpha polypeptides are provided, including linking the polypeptide to an albumin-binding domain and/or de-immunizing the polypeptide, to provide therapeutic agents with good solubility, enhanced serum half-life, and/or reduced immunogenicity, while substantially maintaining the specific binding properties of the anti-Tumor Necrosis Factor-alpha polypeptides. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN103906765A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN103906765A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN103906765A3</originalsourceid><addsrcrecordid>eNrjZLBwzCvJ1C0pzc0vUshLTS7KL84sVkhLTC7JL9JNzCnISFRITE_NKylWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGxpYGZuZmpo7GxKgBAAu8LlM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-tumor necrosis factor-alpha agents and uses thereof</title><source>esp@cenet</source><creator>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO ; FERREIRA LLORENTE GRANCHO LOURENCO SARA ; VOLKER CORTE-REAL SOFIA ; CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</creator><creatorcontrib>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO ; FERREIRA LLORENTE GRANCHO LOURENCO SARA ; VOLKER CORTE-REAL SOFIA ; CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</creatorcontrib><description>The present invention relates to polypeptides comprising one or more antibody single domains, or antigen-binding fragments thereof, directed against Tumor Necrosis Factor-alpha, in particular, two light chain variable domains in dimeric form, wherein the dimer has high solubility. It also relates to methods of using anti-Tumor Necrosis Factor-alpha polypeptides in treating inflammatory disorders, including rheumatoid arthritis. Compositions and methods for enhancing therapeutic potential of anti-Tumor Necrosis Factor-alpha polypeptides are provided, including linking the polypeptide to an albumin-binding domain and/or de-immunizing the polypeptide, to provide therapeutic agents with good solubility, enhanced serum half-life, and/or reduced immunogenicity, while substantially maintaining the specific binding properties of the anti-Tumor Necrosis Factor-alpha polypeptides.</description><language>chi ; eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140702&DB=EPODOC&CC=CN&NR=103906765A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140702&DB=EPODOC&CC=CN&NR=103906765A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO</creatorcontrib><creatorcontrib>FERREIRA LLORENTE GRANCHO LOURENCO SARA</creatorcontrib><creatorcontrib>VOLKER CORTE-REAL SOFIA</creatorcontrib><creatorcontrib>CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</creatorcontrib><title>Anti-tumor necrosis factor-alpha agents and uses thereof</title><description>The present invention relates to polypeptides comprising one or more antibody single domains, or antigen-binding fragments thereof, directed against Tumor Necrosis Factor-alpha, in particular, two light chain variable domains in dimeric form, wherein the dimer has high solubility. It also relates to methods of using anti-Tumor Necrosis Factor-alpha polypeptides in treating inflammatory disorders, including rheumatoid arthritis. Compositions and methods for enhancing therapeutic potential of anti-Tumor Necrosis Factor-alpha polypeptides are provided, including linking the polypeptide to an albumin-binding domain and/or de-immunizing the polypeptide, to provide therapeutic agents with good solubility, enhanced serum half-life, and/or reduced immunogenicity, while substantially maintaining the specific binding properties of the anti-Tumor Necrosis Factor-alpha polypeptides.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBwzCvJ1C0pzc0vUshLTS7KL84sVkhLTC7JL9JNzCnISFRITE_NKylWSMxLUSgtTi1WKMlILUrNT-NhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGxpYGZuZmpo7GxKgBAAu8LlM</recordid><startdate>20140702</startdate><enddate>20140702</enddate><creator>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO</creator><creator>FERREIRA LLORENTE GRANCHO LOURENCO SARA</creator><creator>VOLKER CORTE-REAL SOFIA</creator><creator>CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</creator><scope>EVB</scope></search><sort><creationdate>20140702</creationdate><title>Anti-tumor necrosis factor-alpha agents and uses thereof</title><author>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO ; FERREIRA LLORENTE GRANCHO LOURENCO SARA ; VOLKER CORTE-REAL SOFIA ; CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN103906765A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO</creatorcontrib><creatorcontrib>FERREIRA LLORENTE GRANCHO LOURENCO SARA</creatorcontrib><creatorcontrib>VOLKER CORTE-REAL SOFIA</creatorcontrib><creatorcontrib>CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DA SILVA ALBUQUERQUE E. FREITAS RUI PEDRO</au><au>FERREIRA LLORENTE GRANCHO LOURENCO SARA</au><au>VOLKER CORTE-REAL SOFIA</au><au>CASTANHEIRA AIRES DA SILVA FREDERICO NUNO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-tumor necrosis factor-alpha agents and uses thereof</title><date>2014-07-02</date><risdate>2014</risdate><abstract>The present invention relates to polypeptides comprising one or more antibody single domains, or antigen-binding fragments thereof, directed against Tumor Necrosis Factor-alpha, in particular, two light chain variable domains in dimeric form, wherein the dimer has high solubility. It also relates to methods of using anti-Tumor Necrosis Factor-alpha polypeptides in treating inflammatory disorders, including rheumatoid arthritis. Compositions and methods for enhancing therapeutic potential of anti-Tumor Necrosis Factor-alpha polypeptides are provided, including linking the polypeptide to an albumin-binding domain and/or de-immunizing the polypeptide, to provide therapeutic agents with good solubility, enhanced serum half-life, and/or reduced immunogenicity, while substantially maintaining the specific binding properties of the anti-Tumor Necrosis Factor-alpha polypeptides.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN103906765A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Anti-tumor necrosis factor-alpha agents and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T10%3A57%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DA%20SILVA%20ALBUQUERQUE%20E.%20FREITAS%20RUI%20PEDRO&rft.date=2014-07-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN103906765A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |